|
APTOSE BIOSCIENCES Inc. (APTO) Évaluation DCF
CA | Healthcare | Biotechnology | NASDAQ
|
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Aptose Biosciences Inc. (APTO) Bundle
Améliorez votre stratégie d'investissement avec la calculatrice DCF d'Aptose Biosciences Inc. (APTO)! Explorez des données financières authentiques, ajustez les projections et dépenses de croissance et observez instantanément comment ces modifications affectent la valeur intrinsèque d'Aptose Biosciences Inc. (APTO).
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | -26.3 | -57.5 | -64.2 | -39.7 | -52.3 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Depreciation | .6 | .6 | .6 | .5 | .1 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -26.9 | -58.2 | -64.8 | -40.2 | -52.4 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Total Cash | 97.6 | 122.4 | 79.1 | 47.0 | 9.3 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Accounts Payable | 2.0 | 2.2 | 1.7 | 6.3 | 6.0 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | -.1 | -.1 | -.2 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -26.3 | -57.6 | -64.7 | -39.4 | -52.4 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -23.8 | -56.8 | -64.8 | -34.3 | -52.6 | -6.0 | .0 | .0 | .0 | .0 |
| WACC, % | 8.15 | 8.15 | 8.15 | 8.15 | 8.15 | 8.15 | 8.15 | 8.15 | 8.15 | 8.15 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -5.6 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -6 | |||||||||
| Net Debt | -8 | |||||||||
| Equity Value | 3 | |||||||||
| Diluted Shares Outstanding, MM | 7 | |||||||||
| Equity Value Per Share | 0.39 |
What You Will Receive
- Customizable Excel Template: A fully adjustable Excel-based DCF Calculator featuring pre-loaded real APTO financials.
- Accurate Data: Historical performance data and future projections (highlighted in the yellow cells).
- Assumption Flexibility: Modify forecast parameters such as revenue growth, EBITDA %, and WACC.
- Instant Calculations: Quickly observe how your inputs affect Aptose’s valuation.
- Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
- Intuitive Layout: Organized for clarity and ease of navigation, complete with step-by-step guidance.
Key Features
- Comprehensive Financial Data: Gain access to precise historical performance metrics and future forecasts for Aptose Biosciences Inc. (APTO).
- Adjustable Projection Parameters: Modify highlighted fields such as WACC, expected growth rates, and profit margins.
- Real-Time Financial Calculations: Automatic recalculations for DCF, Net Present Value (NPV), and cash flow assessments.
- User-Friendly Visual Interface: Intuitive charts and summaries for clear visualization of your financial analyses.
- Designed for All Levels: An accessible layout tailored for investors, financial officers, and consultants alike.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review Aptose Biosciences Inc.'s pre-filled financial data and forecasts.
- Step 3: Modify critical inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Watch the DCF model update instantly as you adjust your assumptions.
- Step 5: Analyze the outputs and utilize the results for your investment decisions.
Why Choose This Calculator for Aptose Biosciences Inc. (APTO)?
- Comprehensive Tool: Integrates DCF, WACC, and financial ratio analyses tailored for biotech firms.
- Customizable Inputs: Modify yellow-highlighted cells to explore different financial scenarios for APTO.
- Detailed Insights: Automatically computes Aptose's intrinsic value and Net Present Value.
- Preloaded Data: Historical and projected data provide reliable starting points for analysis.
- Professional Quality: Perfect for financial analysts, investors, and biotech consultants focusing on APTO.
Who Should Use This Product?
- Investors: Accurately assess Aptose Biosciences Inc.'s (APTO) fair value prior to making investment choices.
- CFOs: Utilize a professional-grade DCF model for financial reporting and analysis specific to Aptose Biosciences Inc. (APTO).
- Consultants: Efficiently customize the template for valuation reports tailored to Aptose Biosciences Inc. (APTO) clients.
- Entrepreneurs: Acquire insights into financial modeling practices employed by leading biotech firms like Aptose Biosciences Inc. (APTO).
- Educators: Implement it as a teaching resource to illustrate valuation techniques relevant to the biotech sector.
What the Template Contains
- Preloaded APTO Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.